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1Chapter
Dengue Virus and the Relationship 
with MicroRNAs
Samir Casseb and Karla de Melo
Abstract
Dengue is an acute febrile disease caused by a virus of the genus Flavivirus, 
family Flaviviridae, endemic in tropical regions of the globe. The agent is a virus 
with single-stranded RNA, classified into four distinct dengue virus (DENV) 
serotypes: DENV-1, DENV-2, DENV-3, and DENV-4. The host’s innate and adaptive 
immune responses play an essential role in determining the natural history of viral 
infections, especially in dengue. In this context, it has observed in recent years that 
the presence of RNA interference (RNAi) in viral infection processes is increasing, 
as well as immune defense. The context microRNAs (miRNAs) go for stood out, 
as their presence during viral infection, both in the replication of the virus and in 
the defense against these infections, becomes increasingly noticeable, therefore, 
making it increasingly necessary to better understand the role of these small RNAs 
within viral infection by DENV and what their consequences are in aggravating the 
consequences of patients affected by this disease.
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1. Introduction
RNA interference (RNAi) is understood as the mechanism of gene silencing 
through transcription or post-transcription. Post-transcription gene  silencing 
(PTGS) operates through translational repression induced by microRNAs 
( miRNAs), from precursors transcribed in the nucleus [1].
The silencing machinery by microRNAs directs mRNA to the P bodies present 
in the cytoplasm. They are deprived of the translation machinery and conserve 
proteins involved in the degradation of the target mRNA [2].
The natural functions of RNAi and their related processes appear to be the pro-
tection of the genome against invasion by mobile genetic elements, such as viruses 
and transposons, as well as the functioning of eukaryotic organism development 
programs [3, 4].
These analyses led to the identification of proteins encoded by the host involved 
in gene silencing. Also, they revealed that several enzymes or essential factors are 
common to these processes. Some components have identified to serve as initia-
tors. In contrast, others serve as effectors, amplifiers, and transmitters for the gene 
silencing process [5].
The RNAi is widely used to fight viruses, due to the exposure of their genetic 
material in the intracellular environment at various stages of their replication 
cycle [6, 7]. Due to the distinction between viral and cellular genomes, the 
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chances of cross-silencing are low. In contrast, mutational changes in the viral 
genome allow mechanisms to escape interference pathways [8, 9].
2. miRNA
The microRNAs are defined as small single-stranded RNA molecules with 
approximately 19–25 nucleotides, not protein encoders, that act as mediators for the 
regulation of the posttranscriptional gene expression [10].
The first miRNA was described in 1993 and related to the regulation of larval 
development in Caenorhabditis elegans. However, understand that the miRNA 
class is the largest class of gene regulators, with around 1000 miRNAs. Promoting 
regulation is necessary to bind the 3’untranslated region of the target mRNA [11].
There are more than 2500 miRNAs identified in the human genome. Although 
transcriptional targets are predicted, most of these have not been validated, which 
makes this area for investigation rich [6, 12]. Studies revealed that viruses encode 
miRNA, for example, Epstein-Barr virus (EBV), human cytomegalovirus (HCMV), 
and human immunodeficiency virus type 1 (HIV-1) [13].
miRNAs play essential roles in the cell, such as proliferation, differentiation, 
apoptosis, stress response, and transcriptional regulation. Studies have shown that 
miRNAs change their expression in several pathologies, increasing their importance 
and the need for a better understanding of this process [14].
2.1 miRNA biogenesis and mechanism of action
The miRNA biogenesis process consists of transcription, export, processing, and 
maturation, at the cytoplasmic and cellular levels. As a fundamental element of this 
miRNA transcription, RNA polymerases II and III are found, with the function of 
transcribing gene encoding proteins [12].
Currently, most of the identified miRNAs are intragenic and processed from 
introns. Simultaneously, the rest are intergenic and transcribed independently of 
a host gene and regulated by their promoters [15]. Sometimes, miRNAs are tran-
scribed as a long transcript called “clusters,” which can have similar regions, and, 
in this case, are considered a family. miRNA biogenesis can be classified into two 
pathways: canonical and noncanonical (Figure 1) [5].
What defines the choice of these mechanisms is the complementarity between 
the bases of miRNA and mRNA. When there is perfect parity between the bases, 
degradation of the mRNAs will occur [16]. On the other hand, incomplete pairings 
generate inhibition of the translation of the target mRNA. Since miRNAs are small 
molecules, there is no need for complete pairing for binding. Thus, a miRNA can 
act in the regulation of several target mRNAs, or several miRNAs regulate a single 
mRNA [17].
2.1.1 Canonical pathway
The canonical pathway of biogenesis is the dominant pathway by which miRNAs 
are processed. In this way, pri-miRNAs are transcribed from their genes and pro-
cessed into pre-miRNAs by the microprocessor complex, consisting of a protein that 
binds RNA to the critical region of DiGeorge syndrome 8 (DGCR8) and a ribonucle-
ase III enzyme, Drosha [18]. DGCR8 recognizes an N6-methyladenylated GGAC 
and other motifs within the pri-miRNA [19]. At the same time, Drosha cleaves the 
duplex pri-miRNA based on the characteristic structure of the pri-miRNA, resulting 
in the formation of an excess of 2 nt 3′ in the pre-miRNA [20]. Once pre-miRNAs 
Please use Adobe Acrobat Reader to read this book chapter for free.
Just open this same document with Adobe Reader.
If you do not have it, you can download it here.
You can freely access the chapter at the Web Viewer here.
S curing Connection...Acrobat i  locking documen loading.com
r
File cannot be found.
3Dengue Virus and the Relationship with MicroRNAs
DOI: http://dx.doi.org/10.5772/intechopen.92453
are generated, they are exported to the cytoplasm by an exportin 5 (XPO5)/RanGTP 
complex and processed by the RNase III Dicer endonuclease [5, 22].
This processing involves removing the loop from the terminal, resulting in a 
mature miRNA duplex. The directionality of the miRNA chain determines the 
name of the mature miRNA form. The 5p chain emerges from the 5′ end of the pre-
miRNA hairpin, while the 3p chain originates from the 3′ end. Both chains derived 
from the mature miRNA duplex can carry in the Argonaute family of proteins. 
miRNA chains that do not contain incompatibilities are cleaved by AGO2 and 
degraded by cellular machinery that can produce a strong chain bias. Otherwise, 
miRNA duplexes with central mismatches or miRNA not loaded with AGO2 are pas-
sively unwound and degraded [23].
Figure 1. 
MicroRNA biogenesis and mechanism of action. The canonical miRNA biogenesis begins with the generation 
of the pri-miRNA transcript passing through the microprocessor complex, composed of the critical region 8 
of Drosha and DiGeorge syndrome (DGCR8), and cleaves the pri-miRNA to produce the precursor miRNA 
(pre-miRNA). The mature miRNA is associated with the Argonaute (AGO) protein family forming a miRNA-
induced silencing complex (miRISC). In noncanonical pathways, small hairpin RNA (shRNA) is initially 
cleaved by the microprocessor complex and exported to the cytoplasm via exportin 5/RanGT, cleaved by AGO2, 
but this action is independent of Dicer (modified by Tanzer et al.) [21].
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2.1.2 Noncanonical pathway
Several noncanonical biogenesis pathways in miRNA are elucidated (Figure 1). 
These pathways make use of combinations of proteins involved in the canonical 
pathway, mainly Drosha, Dicer, exportin 5, and AGO2. The noncanonical miRNA 
can be grouped into Drosha-/DGCR8-independent and Dicer-independent path-
ways [24, 25].
The pre-miRNAs produced by the Drosha-/DGCR8-independent pathway 
resemble Dicer products. On the other hand, Dicer-independent miRNAs are 
processed by Drosha from endogenous RNA transcripts of hairpins. These pre-
miRNAs require AGO2 to complete their maturation in the cytoplasm. They are of 
insufficient length to be the substrates for Dicer. That, in turn, promotes the loading 
of the entire pre-miRNA in the AGO2 slicing [26, 27].
2.1.3 Argonaute and TNRC6 proteins
The proteins of the Argonaute family are related to the RISC complex, as a mem-
ber of the machinery of the RNAi pathways [28]. The highly conserved between 
species and several organisms encode several members of the family. Usually found 
in the cytoplasm are concentrated close to the P bodies [29].
Such proteins, therefore, act with the transcriptional and posttranscriptional 
silencing pathways. The main stage of the interference mechanism is the cleavage of 
mRNAs; the Argonaute protein in the RISC complex catalyzes this process [28].
Argonautes are applied in transcriptional and posttranscriptional gene silencing, 
acting through the modulation of the degradation or inhibition of the translation of 
specific mRNAs, when associated with miRNAs [18].
The miRNAs associated with Argonaute proteins constitute a more massive 
complex called the miRNA-induced silencing complex, which will suppress the 
expression of mRNAs. In addition to interference at the translational level, it 
shows that miRNAs can induce poly(A) tail deadening [18, 19]. Studies suggest 
that proteins of the TNRC6 family are essential components when associated 
with miRISCs, for the location of cytoplasmic P bodies and the gene silencing of 
mRNAs [19, 20].
3. miRNA and dengue virus
The dengue virus is a virus composed of a single-stranded positive RNA belong-
ing to the family Flaviviridae. DENV serotypes have been identified (DENV-1 to 
DENV-4). All serotypes are causing similar diseases and similar symptoms, without 
significant severity and serious diseases, such as dengue hemorrhagic fever and 
dengue shock syndrome. The DENV genome is approximately 11 kb in length that 
encodes a single polyprotein. This polyprotein is cleaved posttranslationally by the 
host and viral proteases into three structural proteins (capsid C; pre-membrane/
membrane, prM/M; envelope, E) and seven nonstructural proteins (NS1, NS2A, 
NS2B, NS3, NS4A, NS4B, and NS5) [30, 31].
The DENVs enter their target cells via receptor-mediated endocytosis in a 
clathrin-dependent manner. An acidified endosomal vesicle, virion, undergoes con-
formational changes that allow fusion and endosomal membrane and release RNA 
from the genome into the cytosol. After initial translation and cleavage of poly-
protein, DENV triggers the formation of a replication complex in the perinuclear 
endoplasmic reticulum, and RNA replication and protein translation occur. Protein 
C then packages the newly synthesized positive RNA assembled into a virion, which 
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is covered with prM/E heterodimers. When the vesicles containing the immature 
virions move through the Golgi apparatus, the prM is cleaved by a furin protease. 
Finally, immature virions become mature or partially mature virions, which are 
secreted [32, 33].
3.1 Mosquitoes, miRNAs, and dengue
The functions that miRNA is involved in mosquitoes are related to posttran-
scriptional regulation of gene expression in physiological and immunological 
pathways and affect development, metabolism, host-pathogen interactions, and 
resistance to insecticides [34].
3.1.1 Development and metabolism
The specific expression of the miRNA stage in the four stages of development 
(eggs, larvae, pupae, and adults) was confirmed using sequencing. Understand the 
role of regulated miRNAs in the development of the mosquito and the action of 
knocking down the expressed miRNAs in a specific way carried out in Ae. albopictus. 
The knockdown of aal-miR-286b and aal-miR-2942 decreased the hatching of 
embryos and the hatching rate of larvae, respectively, compared to the knock-in 
groups. Reduced longevity and fertility (aal-miR-1891) were observed in the knock-
down groups for miR-1891 compared to the knock-in and control groups in adults. 
Female mosquitoes require sugar for energy metabolism and a blood meal for egg 
development. Recent studies have indicated that blood supply leads to the differ-
ential expression of many genes, proteins, and miRNAs. The abundance of miRNA 
differs under sugar-fed and blood-fed conditions; ast-miR-2796-5p was observed 
exclusively in sugar-fed. The depletion of aae-miR-275 in Ae. aegypti females led 
to severe defects in blood digestion, fluid excretion, and egg development. aae-
miR-1890 is induced after blood feeding and reaches a peak of 24 PMB. The sys-
temic depletion of aae-miR-1890 resulted in less egg development and deposition, 
suggesting that miR-1890 may be the key to mosquito blood digestion. In contrast 
to the upregulated miRNAs after blood feeding, some miRNAs were downregulated. 
For example, reduced ast-miR-989 was observed 72 h after a blood meal. aga-let7 
decreased in the midgut and other parts/leftovers, but most miRNAs increased after 
blood feeding [35–37].
3.1.2 Mosquitoes and dengue infection
The viruses of the Flavivirus genus are transmitted by mosquitoes and cause 
diseases, including dengue. It is observed that Cx. quinquefasciatus mosquitoes 
with West Nile virus (WNV) showed altered miR-92 and miR-989 expressions. In 
Aedes albopictus, the aae-miR-2940 miRNA is downregulated in response to WNV 
infection to restrict viral replication. In studies, the expressions of 35 miRNAs 
of mosquitoes modulating DENV infection in Aedes aegypti and more than 66 
miRNAs were reported. Ae. albopictus is differentially expressed after DENV-2 
infection. Therefore, aal-miR-34-5p and aal-miR-87 contribute to antipathogenic 
and immunological responses during DENV-2 infection. ae-miR-375 is the key to 
DENV replication, which can improve DENV-2 infection in an Ae. aegypti cell line. 
aae-miR-252 is three times more expressed after DENV-2 infection in Ae. albopictus 
cell line (C6/36); this inhibited DENV replication by suppressing the expression 
of the envelope protein of DENV. Regarding aal-miR-281, an abundant miRNA 
specific to the midgut, it was found that it facilitates the replication of DENV-2 in 
Ae. albopictus [36, 37].
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4. miRNA impact on DENV infection
Studies have demonstrated the importance of miRNAs in viral infections. 
Mutations in the main catalytic components of the RNA interference pathway led 
to an increase in DENV replication in mammalian cells (Figure 2) [38]. Studies that 
analyzed the expression of miRNA in the blood of patients with dengue demon-
strated a large number of miRNAs expressed differently in response to dengue 
infections [35]. About 348 miRNAs were described with different expressions in 
patients with dengue. Interestingly, studies have also identified 17 miRNAs that 
could use to distinguish between mild and severe dengue with complications [39].
The expressions of miR-24-1-5p, miR-512-5p, and miR-4640-3p were able to 
distinguish mild dengue from those with liver complications. At the same time, 
miR-383 was significantly more expressed in dengue with mild clinical status than 
those diagnosed with severe dengue and accumulation of body fluids [40, 41].
Studies have also shown 12 miRNAs with negative regulation and 41 with 
positive regulation in the serum of patients infected with DENV-1 when com-
pared to the control group. Among these miRNAs we highlight hsa-miR-21-5p, 
hsa-miR-146a-5p, hsa-miR-590-5p, hsa-miR-188-5p, and hsa-miR-152-3p that 
were identified as promising invasive molecular markers for the detection of 
DENV infection [42, 43].
The microRNAs miR-21-5p and miR146a-5p are involved in inflammation and 
cell proliferation. They are expressed significantly concerning the control group, 
indicating their sensitivity and specificity as indicators of DENV infection. Besides, 
both miRNAs are correlated with the number of leukocytes and neutrophils. These 
findings suggested that some miRNAs could be used as diagnostic markers for 
DENV infections [44].
Effective disruption of host RNAi machinery is one of the pathogenic strategies 
of viruses to mitigate the host’s response. Several viruses have reported produc-
ing protein suppressors through RNAi to cause silencing in infected cells, thereby 
Figure 2. 
An example of increased miRNA expression after the entry of vesicular stomatitis virus (VSV), Japanese 
encephalitis virus (JEV), and dengue virus in mammalian cells. miRNA expression increased in a RIG-I-
dependent manner. The RIG-I protein interacts with viral RNA through its helicase domain, leading to nuclear 
transcription of the pri-miRNA by NF-kB. The reduction of target mRNAs explains the proviral function of 
this miRNA as the response of interferon type I (adapted from Bruscella et al.) [45].
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interfering with RISC’s loading or inhibiting the cutting activity of the AGO 
protein, a component of RISC and the biogenesis of miRNAs. DENV also has such 
suppressors that could neutralize the host’s RNAi response. NS4B has reported 
suppressing host RNAi, interfering with the processing of Dicer, a key protein in 
miRNA biogenesis [38]. It has also reported that NS1 protein can interfere with 
apoptosis through miRNA-15 and miRNA-16 [5]. The NS3 protein has shown to 
interfere with the AGO1 protein [46].
5. miRNAs and the inhibition of viral replication
The miRNAs generally induce translational repression by binding to target 
mRNAs. Thus, it is not surprising that most of the miRNAs identified so far have 
DENV replication. The evidence points to the fact that miRNAs bind complemen-
tarily to the DENV 5’UTR or 3’UTR genome and thus inhibit DENV replication. 
The miR-548 g-3p represented the first evidence that a miRNA suppresses DENV 
multiplication by directly linking it to the viral genome. In the study, they showed 
that miR-548 g-3p was able to bind to the stem-loop A (SLA) promoter at 5’UTR, 
which is a crucial element for DENV RNA synthesis and replication, and uncon-
trolled replication of DENV-1. This inhibitory effect was proposed to arise from the 
binding of miR-548 g-3p to SLA, which could make it physically difficult, and thus 
attenuated the interaction between the SLA promoter and NS5. This DENV protein 
contains a C-dependent RNA-terminal RNA polymerase domain [45, 47].
Their hypothesis suggests that a functional miRNA has been preserved among 
all DENV serotypes and is present in the 3’UTR. The three dengue serotypes, 
miR-133a, miR-484, and miR-744, are involved in DENV replication, genome 
circularization, and viral viability. The overexpression of miR-133a, miR-484, and 
miR-744 in Vero cells had been experimentally validated to show the potencies of 
these three miRNAs in inhibiting DENV replication [48]. In another study, it found 
that miR-252 can inhibit DENV-2 replication in cell culture. The identification of 
protein E as a target for this miRNA is interesting since it has an indispensable role 
for viral entry [49, 50].
6.  miRNAs that modulate host factors to inhibit or facilitate DENV 
replication
The DENV virus depends on its host’s machinery for replication and infection, 
and it is not surprising that several miRNAs have shown to indirectly regulate 
DENV replication through modulation of host factors or the immune response. 
These indirect effects included modulation of the expression of a cell transcript 
that encodes a host factor necessary for one or a few stages of the viral cycle. The 
modulation of receptor expression can regulate virus entry, tropism, and essential 
cofactors for replication or translation that can impair or increase viral replication 
and the production of viral proteins. Also, miRNAs can increase or restrict cellular 
responses to viral infection, such as immune response or defense mechanisms [51].
The miRNA let-7c is highly expressed in Huh-7 cells and may be related to the 
protection of infected cells from oxidative stress and the response to inflammation 
after DENV infection. Let-7c has shown to bind directly to the basic transcription 
factor-1 of the leucine zipper (BACH1), a potent repressor of the anti-inflammatory 
and antioxidant protein heme oxygenase-1 (HO-1), and to dysregulate infection by 
DENV-2 and DENV-4. In this way, let-7c is probably able to protect the host from 
virus-induced infection [49].
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In addition to modulating the host’s immune response, miRNA may have 
antiviral actions. An example is miR-223, capable of inhibiting DENV-2 replica-
tion; its antiviral effect is probably associated with attenuated expression of the 
microtubule-destabilizing protein, stathmin 1 (STMN1), a key regulator of protein 
microtubules that controls microtubule dynamics [52]. The exact mechanism of 
how STMN1 affected DENV-2 replication is not yet known. However, studies have 
shown that an intact microtubule network involved in STMN1 sequestration was 
essential for HMCV to establish an infection. As such, it is highly likely that STMN1 
is playing a similar role in establishing controlled microtubule dynamics in the 
context of DENV infection [53].
It is important to emphasize that despite all studies and the discovery of several 
miRNAs associated with cell regulation positively or negatively, better clarification 
of the processes involving miRNAs and DENV is still needed.
6.1 Perspective
6.1.1 Diagnostic using miRNA
As already reported in this chapter, several human diseases were induced due 
to differential miRNA expressions. Recently, several studies have confirmed the 
vibrant role of miRNAs in the successful regulation of various biological processes 
through the synergistic effects of the multiple miRNA networks, an integrated way 
to control an individual gene [17].
Also, several physiological functions (such as development, infection, immune 
response, inflammation, tumor genesis, and regulation of bone mass) have sug-
gested being controlled by miRNAs. The miRNAs can regulate gene expression 
at the posttranscriptional level of more than 50% of the protein-coding genes 
in humans.
The miRNAs were found to play roles in helping and defending viruses. 
Mammalian miRNA genes generally exist in the noncoding region of the genes. 
However, they also occur both in the exonic regions of the gene encoding protein 16, 
and in alternative exon splicing, it can also regulate the expression of miRNA inter-
ionic genes. Study results show a role for unregulated autophagy in the pathogenesis 
of some RNA viruses. In this context, the positive regulation of hsa-miR-31 and the 
negative regulations of hsa-miR-493, hsa-miR-889, hsa-miR-655, hsa-miR-656, hsa-
miR-26a-1, hsa-miR-154, hsa-miR-335, hsa-miR-1197, and hsa-miR-146a improve 
innate antiviral responses in cells infected by the virus [26].
Thus, this study aimed at the expression of these miRNAs during dengue 
infection; in this way, monitoring possible changes can be used as a complementary 
diagnostic method for faster interventions that can prevent more severe clinical 
conditions in patients infected with dengue.
6.1.2 Role of RNAi in dengue therapy
To date, miRNAs are used against some viruses that cause disease in humans, 
including influenza viruses, hepatitis C viruses, hepatitis B viruses, human immu-
nodeficiency virus type 1, polio, and DENV. These viruses are characterized by the 
presence of ssRNA genomes, which are potential targets for RNAi in the cytoplasm. 
This functional interaction occurred during the removal and replication of viral 
RNA [15, 54].
Any changes in the miRNA pathway may shed light on why some mosquitoes are 
specific vectors for arthropod-borne virus infections (arboviruses), while others 
are not. The first evidence is the interference of Sindbis viruses that express the 
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recombinant part of the non-inconsequential unrelated RNA (DENV-2), with the 
replication of DENV-2 in mosquitoes (Egyptian Aedes) through a system such as 
the silencing mechanism in plants [55].
Potential evidence may be involved with the interaction of dsRNA or siRNA 
derived from the arbovirus genome. Mammals have thousands of Piwi-interacting 
RNA genes from producer types of microRNA regulation expression to control 
the various stages of cell development and physiology. The critical role of RNAi is 
a defense against viruses in primary organisms, but in mammals, it is the antiviral 
defense mechanism hitherto controversial. Currently, it is a conserved mecha-
nism of RNAi in mammals, where its introduction to siRNA affects the silent 
replication of viruses. Currently, the most significant therapeutic attempt using 
miRNA is to block the “shutdown” actions of genes that end up facilitating viral 
replication [41, 42].
7. Conclusions
It is possible to conclude that miRNA has an important relationship during 
DENV infection, and this regulation can be positive for the virus, that is, facilitat-
ing the entry of the virus and helping in the replication process, but it is important 
to emphasize that there are miRNAs that can also have antiviral action, thereby 
blocking viral replication.
The miRNA studies demonstrate how important this small RNAi is for viral 
infections, whether in arthropod vectors like mosquitoes or mammals like humans.
One of the significant difficulties in the study of miRNA is the difficulty of 
understanding all of its relationships within the cell. Thus, further studies are 
needed to elucidate more forcefully what the functions of each miRNA are with the 
cell cycle and the viral replication cycle. Nevertheless, these RNAs have been bring-
ing great perspectives both in treatment and as markers for DENV.
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